Medication app boosts psoriasis patients’ short-term adherenceAugust 30, 2018PsoriasisPsoriatic Arthritis
Risankizumab proves more effective in psoriasis than ustekinumabAugust 28, 2018PsoriasisPsoriatic Arthritis
Psoriasis registry study provides more data on infliximab’s infection riskAugust 16, 2018PsoriasisPsoriatic ArthritisMixed Topics
FDA announces plan for biosimilar innovation and competitionJuly 19, 2018PsoriasisPsoriatic ArthritisBusiness of Medicine
Elderly patients with psoriasis can benefit from biologics with low rates of adverse eventsJune 29, 2018Psoriatic ArthritisPsoriasis
Adalimumab strikes out for aortic inflammation in psoriasisJune 27, 2018PsoriasisMixed TopicsPsoriatic Arthritis
Biologic efficacy differs in psoriatic arthritis by lymphocyte phenotypeJune 25, 2018Psoriatic Arthritis
Psoriasis therapy with biologics not linked to increased cancer riskMay 30, 2018PsoriasisNonmelanoma Skin CancerMixed TopicsPsoriatic Arthritis
Psoriatic arthritis patients’ cardiovascular risks aren’t spurring increased managementMay 23, 2018Psoriatic Arthritis
